Acer therapeutics reports q4 and full year 2021 financial results and provides corporate update

Newton, mass., march 02, 2022 (globe newswire) -- acer therapeutics inc. (nasdaq: acer), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today reported financial results for the fourth quarter and full year ended december 31, 2021 and provided an update on the company's recent corporate developments.
ACER Ratings Summary
ACER Quant Ranking